92823 ⎘
Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS
#2AMINO LIPID COMPOUND, PREPARATION METHOD THEREFOR, COMPOSITION THEREOF AND APPLICATION THEREOF
#3LIPID COMPOUND, LIPID NANOPARTICLE COMPRISING SAME AND USE THEREOF
#4KETONE INHIBITORS OF LYSINE GINGIPAIN
#5RHEOLOGICAL ADDITIVE BASED ON OPTIONALLY BIOSOURCED 1,5-PENTAMETHYLENEDIAMINE
#6IONIZABLE LIPID, PREPARATION METHOD THEREOF, AND COMPOSITION FOR PREPARING LIPID NANOPARTICLE
#7COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS
#8NITROGEN-BRANCHED NON-LINEAR PEGYLATED LIPID CONTAINING A TERTIARY AMINE AND APPLICATION THEREOF
#9TARGETED COMPOSITIONS
#10NITROGEN-CONTAINING CATIONIC LIPID AND APPLICATION THEREOF
#11TARGETED NUCLEIC ACID CONJUGATE COMPOSITIONS
#12NOVEL LIPID COMPOUND AND LIPID NANOPARTICLE COMPOSITION COMPRISING THE SAME
#13POLYMERS PREPARED FROM MEVALONOLACTONE AND DERIVATIVES
#14TRPM8 AGONISTS AS COOLING AGENTS AND FOR THE TREATMENT OF DISEASE
#15Compounds and compositions for intracellular delivery of therapeutic agents
#165-HYDROXY-1,4-NAPHTHALENEDIONE FOR USE IN THE TREATMENT OF CANCER
#17Pantothenamide analogues
#18Ketone inhibitors of lysine gingipain
#19ALKYL LACTONE-DERIVED CORROSION INHIBITORS
#20HYGROSCOPIC HYDROGELS, METHODS AND USES THEREOF FOR WATER COLLECTION
#21Compounds and compositions for intracellular delivery of therapeutic agents
#22COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS
#23LIPIDS AND LIPID NANOPARTICLE FORMULATIONS FOR DELIVERY OF NUCLEIC ACIDS
#24Pantothenamide analogues
#25Rheological additive based on optionally biosourced 1,5-pentamethylenediamine
#26Amide compounds, pharmaceutical compositions thereof, and methods of using the same
#27Alkyl lactone-derived corrosion inhibitors
#28Methods for clay swelling inhibition using gemini surfactants containing a saturated linker
#29Ketone inhibitors of lysine gingipain
#30POLYMERS PREPARED FROM MEVALONOLACTONE AND DERIVATIVES
#31Diesel detergent without a low molecular weight penalty
#32Amidoamine-based gemini surfactant containing ethoxylate units and a method for oil recovery
#33Amino acid derivatives and absorbable polymers therefrom
#34Compounds and compositions for intracellular delivery of therapeutic agents
#35Alkyl lactone-derived corrosion inhibitors
#36Lipids and lipid nanoparticle formulations for delivery of nucleic acids
#37Ketone inhibitors of lysine gingipain
#38Antibacterial agents
#39Targeted nucleic acid conjugate compositions
#40Process for synthesizing an amido alkyl betaine starting from an alcohol, an amido alkyl betaine prepared by the process with increased viscosity, and use thereof as a viscoelastic surfactant
#41Diesel detergent without a low molecular weight penalty
#42Compounds and compositions for intracellular delivery of therapeutic agents
#43Pantothenamide Analogues
#44Compounds and compositions for intracellular delivery of therapeutic agents
#45Necrosis inhibitors
#46Compounds and compositions for intracellular delivery of therapeutic agents
#47Amino acid derivatives and absorbable polymers therefrom
#48Compounds and compositions for intracellular delivery of therapeutic agents
#49Compounds and compositions for intracellular delivery of therapeutic agents
#50Lipids and lipid nanoparticle formulations for delivery of nucleic acids
#51Amino acid derivatives and absorbable polymers therefrom
#52Cycloaliphatic and aliphatic diamine-based fatty acid diamides used as organogelators
#53Polyamine transport inhibitors as novel therapeutics
#54Nitrogen containing surfactants with alkoxylation on the hydroxyl group of fatty chains
#5514-HYDROXYEICOSANOIC ACID-BASED FATTY ACID AMIDE, AS AN ORGANOGELLING AGENT
#56Diesel detergent without a low molecular weight penalty
#57Diesel detergent without a low molecular weight penalty
#58Lipase-stable thickening agent
#59Macromolecules for treating atherosclerosis
#60Polyamine derivatives
#61Methods of using prodrugs of methyl hydrogen fumarate and pharmaceutical compositions thereof
#62Metal plating compositions and methods
#63Polyamine derivatives
#64Polyamine derivatives
#65SALICYLATE FATTY ACID DERIVATIVES
#66Use of ruthenium complexes for formation and/or hydrogenation of amides and related carboxylic acid derivatives
#67Polyamine transport inhibitors as novel therapeutics
#68Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
#69Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use
#70Methods of using prodrugs of methyl hydrogen fumarate and pharmaceutical compositions thereof
#71Fluorinated ether compounds and methods of using the same
#72MODIFIED POLY(PROPYLENE-IMINE) DENDRIMERS AND THEIR USE AS TRANSFECTION AGENTS FOR AMIONIC BIOACTIVE FACTORS ( as amended
#73Boron removal method utilizing sugar amide derivative
#74SUBSTITUTED ACETYLENIC COMPOUNDS USEFUL FOR THE TREATMENT OF DISEASES
#75Polyamine derivatives
#76ACETYL 2-HYDROXY-1,3-DIAMINOALKANES
#77Compounds for the treatment of inflammatory disorders
#78Bridged six-membered ring compounds
#79Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use
#80INSITU SYNTHESIS OF ESTER-AMIDE-CONTAINING MOLECULES
#81Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
#82Zwitterionic compounds and use thereof
#83Flavour modulating substances
#84Alpha, omega-difunctional aldaramides
#85PROCESSES FOR PREPARING POLYMERS USING ALPHA,OMEGA-DIFUNCTIONAL ALDARAMIDES
#86High molecular weight polyamine salts as clay stabilizing agents
#87Polyamine salts as clay stabilizing agents
#88Acetyl 2-hydroxy-1, 3-diaminoalkanes
#89Hydroxypropyl Amides for the Treatment of Alzheimer's Disease
#90Processes using alpha, omega-difunctional aldaramides as monomers and crosslinkers
#91Alpha, omega-difunctional aldaramides
#92High molecular weight polyamine salts as clay stabilizing agents
#93Compounds for the treatment of inflammatory disorders
#94Compounds for the treatment of inflammatory disorders
#95Lipids
#96Novel acyl-dipeptide-like compounds, a method for preparing the same and pharmaceutical compositions containing such products
#97Cationic surfactants
#982-amino- and 2-thio- substituted 1,3-diaminopropanes
#99Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
#100Alkylpolypropyleneoxide amidotriamines and method of using same
#101Polyamine salts as clay stabilizing agents
#102Process for preparing aspartates